CUCINOTTA, MARIAPAOLA
 Distribuzione geografica
Continente #
EU - Europa 1.516
NA - Nord America 795
AS - Asia 226
OC - Oceania 1
SA - Sud America 1
Totale 2.539
Nazione #
IT - Italia 897
US - Stati Uniti d'America 794
IE - Irlanda 256
SE - Svezia 209
CN - Cina 173
IN - India 41
GB - Regno Unito 35
FI - Finlandia 33
PL - Polonia 28
DE - Germania 27
UA - Ucraina 9
BE - Belgio 7
CH - Svizzera 4
FR - Francia 4
IR - Iran 4
RU - Federazione Russa 4
HK - Hong Kong 2
VN - Vietnam 2
AL - Albania 1
AU - Australia 1
BD - Bangladesh 1
BR - Brasile 1
CA - Canada 1
ES - Italia 1
KZ - Kazakistan 1
MY - Malesia 1
PT - Portogallo 1
TR - Turchia 1
Totale 2.539
Città #
Dublin 256
Chandler 215
Nyköping 136
Milan 76
Beijing 74
Ashburn 61
Rome 55
Jacksonville 51
Dearborn 48
Naples 35
Cambridge 34
Princeton 34
Medford 32
Turin 31
New York 30
Des Moines 29
Warsaw 28
Hyderabad 24
Trieste 24
Ann Arbor 21
Genoa 21
Lancaster 21
Messina 21
Jinan 20
Catania 17
Palermo 17
Pune 15
Nanjing 14
Bari 13
Houston 13
Bremen 11
San Mateo 11
Boardman 10
Florence 9
Shenyang 9
Ningbo 8
Brescia 7
Brussels 7
Eboli 7
Hebei 7
Verona 7
Wilmington 7
Parma 6
Prato 6
Syracuse 6
Venice 6
Bergamo 5
Cosenza 5
Ardabil 4
Cagliari 4
Cassano delle Murge 4
Castel San Giorgio 4
Catanzaro 4
Comiso 4
Gragnano 4
Iesi 4
Lucca 4
Modena 4
Modugno 4
Ponte San Pietro 4
Porcia 4
Woodbridge 4
Brindisi 3
Casavatore 3
Castellammare di Stabia 3
Frosinone 3
Guangzhou 3
Haikou 3
Hangzhou 3
Jiaxing 3
Mogliano Veneto 3
Monza 3
Nepi 3
Pescara 3
San Giovanni in Persiceto 3
Seattle 3
Taizhou 3
Udine 3
Zhengzhou 3
Aci Castello 2
Ancona 2
Angri 2
Ascoli Piceno 2
Avellino 2
Aversa 2
Barletta 2
Benevento 2
Biccari 2
Bitonto 2
Bologna 2
Bosco Marengo 2
Carbonara di Nola 2
Carobbio degli Angeli 2
Casoria 2
Castegnero 2
Castel Rozzone 2
Castelbuono 2
Castenaso 2
Ceprano 2
Cerignola 2
Totale 1.749
Nome #
LA LOCALIZZAZIONE ISTMICA DEL NODULO TIROIDEO MALIGNO RAPPRESENTA UN FATTORE ADDIZIONALE DI RISCHIO PER METASTASI IN PAZIENTI AFFETTI DA CARCINOMA DIFFERENZIATO DELLA TIROIDE (CDT) A BASSO RISCHIO 883
Oxidative Stress: Harms and Benefits for Human Health 97
Radiometabolic therapy with 131I for the ablation of the thyroid remnant in patients affected by differentiated thyroid cancer: comparison between four different activities 76
THIONAMIDES-RELATED VASCULITIS IN AUTOIMMUNE THYROID DISORDERS: REVIEW OF CURRENT LITERATURE AND CASE REPORTS 75
Central nervous system vasculitis after starting methimazole in a woman with Graves' disease 66
Hyperthyroidism treatment with calculated activity of 131-Radioiodine: our experience 65
Can the position of malignant thyroid nodule be considered as additional risk factor for recurrent and/or metastatic disease in patients affected by low risk differentiated thyroid cancer? 65
2 years-survival analysis of patients with non-small cell lung cancer by means of 2deoxy-2-[18F]fluoro-D-glucose positron emission tomography: implications of maximum standardized uptake value (SUVmax) 62
Peptide receptor imaging in neuroendocrine tumors: comparison between diagnostic scintigraphy and post-therapy whole-body scan 62
Is malignant nodule topography an additional risk factor for metastatic disease in low-risk differentiated thyroid cancer? 60
A potentially misleading finding at somatostatin receptor scintigraphy: focal pulmonary areas of intense accumulation without computed tomography-detectable lung lesions 56
Hyperthyroidism treatment with calculated activity of 131–radioiodine 56
FOLLICULAR VARIANT OF PAPILLARY THYROID CARCINOMA PRESENTING AS A TOXIC NODULE IN AN ADOLESCENT GIRL 54
ACCIDENTAL DISCOVERY OF LUNG METATSTASES FROM DIFFERENTIATED THYROID CANCER BY TC-99M PERTECHNETATE SCAN IN A PATIENT WITH SECONDARY HYPERPARATHYROIDISM 54
Can the position of malignant thyroid nodule be considered as additional risk factor for recurrent and/or metastatic disease in patients affected by low-risk differentiated thyroid cancer? 52
99mTc-Methoxy-Isobutil-Isonitrile (MIBI) scintigraphy is an useful and cost-effective tool for assessing the risk of malignancy in thyroid nodules with indeterminate fine needle cytology (FNAC) 51
VANTAGGI DELLA DOSIMETRIA PERSONALIZZATA VS ATTIVITA’ STANDARD DI RADIOIODIO NELLA TERAPIA DELL’IPERTIROIDISMO: LA NOSTRA ESPERIENZA 49
Middle-Term Outcome and safety of hyperthyroid patients treated with calculated activity of radioiodine 46
High grade gliomas associated with abscess: description of two rare cases and role of 99mTc-Leukoscan 45
Follicular variant of papillary thyroid carcinoma presenting as toxic nodule in an adolescent: coexistent polymorphism of the TSHR and Gsα genes 45
Middle-term outcome and safety of hyperthyroid patients treated with calculated activity of radioiodine 43
High-grade gliomas associated with abscess: description of two rare cases and role of 99mTc-Leukoscan 42
null 42
Is Detection of Additional Lesions in Post-Peptide ReceptorRadionuclide Therapy Scans With Respect to DiagnosticImaging Only Due to Different Affinity of Ligands?A Report of Discordance Between Diagnostic and Posttherapy Imaging Using the Same Ligand 41
Our experience with peptide receptor radionuclide therapy in patients affected by pulmonary neuroendocrine tumors 41
Is %ΔSUVmax a Useful Indicator of Survival in Patients with Advanced Nonsmall-Cell Lung Cancer? 40
IMPIEGO DEL 99mTC-MIBI PER VALUTARE IL RISCHIO DI MALIGNITA’ DEL NODULO TIROIDEO 39
A didactic experiment showing the Compton scattering by means of a clinical gamma camera 38
Renal function evaluation in patients undergoing repeated peptide receptor radionuclide therapy 35
Lack of association between autonomously functioning thyroid nodules and germline polymorphisms of the thyrotropin receptor and Gαs genes in a mild to moderate iodine-deficient Caucasian population 34
Two-year survival prediction in patients with stage I and II non-small cell lung cancer utilizing 18F-FDG PET/CT SUV quantification 32
Is pre-treatment SUVmax an useful indicator of survival in patients with advanced non-small-cell lung cancer? 30
RADIOIODINE UPTAKE IN ABDOMINAL DERMOID CYST IN A PATIENT WITH DIFFERENTIATED THYROID CANCER (DTC) 27
null 27
Stage III-IV non small cell lung cancer: the impact of SUVmax and %SUVmax in predicting survival after chemotherapy 26
Gliomas with intratumoral abscess formation: Description of new cases, review of the literature, and the role of (99m)TC-Leukoscan 23
Totale 2.579
Categoria #
all - tutte 7.145
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.145


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193 0 0 0 0 0 0 0 0 0 0 1 2
2019/2020193 4 0 2 4 4 45 20 14 12 60 20 8
2020/2021187 15 4 56 6 31 9 5 3 18 12 22 6
2021/2022249 1 30 1 8 15 1 29 8 1 49 30 76
2022/2023787 62 107 36 63 47 59 21 40 307 15 22 8
2023/2024957 22 50 72 73 70 134 103 123 96 202 12 0
Totale 2.579